The Department of Respiratory Medicine of the Civil Aviation Campus of Guangdong Second Provincial General Hospital is a provincial key specialty, a member institution of the Respiratory Disease Specialist Medical Alliance, and a GCP drug clinical trial reserve institution. It is committed to the diagnosis, treatment, and full-cycle rehabilitation management of common, frequently occurring, difficult, and critical respiratory diseases. The department has mature technology and extensive experience in the treatment of critical respiratory illnesses, bronchoscopic interventional therapy, precision diagnosis and treatment of lung cancer, management of chronic airway diseases, and diagnosis and treatment of sleep-related breathing disorders. It has a professionally trained and well-structured medical team, provides multiple specialized disease services, and relies on the MDT multidisciplinary diagnosis and treatment model to offer patients with respiratory diseases precise, individualized, one-stop diagnosis and treatment. It is a highly reputable and capable respiratory disease diagnosis and treatment center in Guangzhou.
I. Specialty Advantages / Specialty Features
(1) Cutting-edge Specialty Technologies
The department has mastered a number of advanced core respiratory diagnosis and treatment technologies in China, covering the entire process of screening, diagnosis, treatment, and rehabilitation. The core technologies are as follows:
1. Treatment technologies for critical respiratory illnesses: invasive mechanical ventilation, non-invasive mechanical ventilation, and bedside bronchoscopy-guided interventional diagnosis and treatment technologies; a high success rate is achieved in the treatment of acute and critical conditions such as ARDS, severe pneumonia, and respiratory failure.
▲ Comparison before and after treatment of “white lung”
▲ Comparison before and after one-sided ventilation treatment for airway obstruction
2. Minimally invasive bronchoscopic interventional technologies: bronchoalveolar lavage, airway stent placement, cryoablation, argon plasma coagulation, and others, covering the full-cycle diagnosis and treatment needs of respiratory diseases.
3. Precision diagnosis and treatment technologies for lung cancer: thoracoscopic segmentectomy and lobectomy; precise diagnostic technologies including transbronchial biopsy (EBUS-TBNA and cryobiopsy) and CT-guided percutaneous lung biopsy; establishment of a lung cancer multidisciplinary diagnosis and treatment (MDT) team to provide individualized chemotherapy, targeted therapy, immunotherapy, and minimally invasive interventional treatment.
4. Precision assessment technologies for chronic airway disease management: follow-up systems and standardized follow-up procedures for asthma and chronic obstructive pulmonary disease; pulmonary function testing, bronchodilation testing, and standardized chronic disease follow-up intervention technologies.
5. Sleep disease diagnosis and treatment technologies: equipped with a polysomnography system; screening, diagnosis, and non-invasive ventilation treatment for sleep apnea syndrome; sleep health guidance.
(2) Authoritative Expert Team
The department currently has 16 medical and nursing staff members. With a well-balanced and strong talent structure, it has formed a professional medical team combining senior, middle-aged, and young members. The team includes physicians with senior professional titles and 4 master’s-level professionals, all with excellent professional expertise and extensive clinical experience. The department’s academic leader has worked in respiratory medicine for many years, holds important positions at or above the level of a standing committee member of provincial academic organizations, and has substantial clinical, scientific research, and academic influence. The department regularly arranges for core team members to undertake further training at renowned Grade III Class A medical institutions in China, continuously updating diagnostic and treatment technologies and concepts and building a technically competent, progressive respiratory specialty team.
(3) Advanced Hardware and Equipment
The department is equipped with a complete set of internationally advanced respiratory specialty diagnosis and treatment equipment, creating a standardized and specialized diagnosis and treatment platform. Relying on an independent respiratory endoscopy center, pulmonary function testing room, sleep respiratory monitoring room, and respiratory intensive care unit (RICU), it is equipped with high-precision pulmonary function testing instruments, a polysomnography system, high-definition electronic bronchoscopes, critical care ventilators, an argon plasma coagulation system, a cryotherapy system, a CT-guided puncture assistance system, and a thoracoscopy system, among other high-end equipment, providing strong hardware support for precise diagnosis, minimally invasive treatment, and critical care rescue. The department has 35 open beds, including 10 RICU intensive care beds, meeting the diagnostic and treatment needs of general patients and the rescue and monitoring needs of critically ill patients.
(4) Research and Teaching Strength
The department integrates medical care, teaching, and scientific research and has strong overall capabilities. In research, it focuses on the pathogenesis of respiratory diseases and the clinical translation of technologies. Relying on its qualification as a GCP drug clinical trial reserve institution, it actively conducts various clinical research projects and promotes innovation and upgrading in respiratory disease diagnosis and treatment technologies. In teaching, it undertakes systematic education and training for medical students, standardized residency trainees, and primary-level visiting trainees. It also regularly organizes provincial- and municipal-level continuing education programs and high-level academic conferences, continuously contributing to the cultivation of regional respiratory medicine professionals and technological progress in the field.
(5) Innovative Diagnosis and Treatment Models
The department implements a lung cancer MDT multidisciplinary joint consultation model, integrating resources from respiratory medicine, thoracic surgery, radiology, pathology, oncology, and other disciplines to tailor individualized comprehensive diagnosis and treatment plans, including chemotherapy, targeted therapy, immunotherapy, and minimally invasive interventional treatment, for patients with pulmonary tumors. It has also established a standardized full-course management model for chronic airway diseases and a one-stop diagnosis and treatment service system for respiratory diseases, realizing closed-loop full-cycle management from disease screening, precise diagnosis, minimally invasive treatment, postoperative rehabilitation, and long-term follow-up, substantially improving diagnosis and treatment efficiency and patient outcomes.
II. Scope of Diagnosis and Treatment
(1) Critical Respiratory Diseases
Acute respiratory distress syndrome (ARDS), severe pneumonia, various types of acute and chronic respiratory failure, severe pulmonary infections, severe airway diseases, postoperative monitoring and treatment after respiratory and cardiac arrest, and other difficult and critical respiratory diseases.
(2) Pulmonary Tumors
Pulmonary nodules, early-stage lung cancer, middle- and late-stage lung cancer, pulmonary space-occupying lesions, and others. Full-course diagnosis and treatment are provided, including screening, precision biopsy, minimally invasive surgery, targeted therapy, immunotherapy, and interventional palliative treatment.
(3) Chronic Airway Diseases
Chronic obstructive pulmonary disease (COPD), bronchial asthma, chronic bronchitis, emphysema, airway stenosis, chronic cough, and others. Standardized treatment and long-term follow-up management are provided.
(4) Sleep-Related Breathing Diseases
Obstructive sleep apnea-hypopnea syndrome, central sleep apnea, snoring, nocturnal hypoxemia, complications related to sleep-related breathing disorders, and others.
(5) Benign Airway and Pulmonary Lesions
Pulmonary infections, bronchitis, bronchiectasis, interstitial lung disease, pleural effusion, pneumothorax, airway polyps, airway scar stenosis, and various common, frequently occurring, and difficult respiratory diseases.
(6) Specialized Disease Diagnosis and Treatment Programs
Specialized pulmonary nodule clinic, specialized precision diagnosis and treatment of lung cancer, specialized chronic disease management for COPD/asthma, specialized sleep-related breathing disorder clinic, specialized critical respiratory illness treatment, and specialized minimally invasive bronchoscopic interventional treatment.
Address of the Department of Respiratory Medicine: Building 3, Civil Aviation Campus of the Second Provincial Medical Hospital
Telephone: 020-89168450
Precision diagnosis, symptomatic treatment, and follow-up management of common respiratory diseases such as pneumonia, bronchial asthma, chronic obstructive pulmonary disease, and bronchiectasis.
李思婕
Attending Physician
Clinical interests
Diagnosis and standardized treatment of common respiratory diseases such as pneumonia, bronchial asthma, and chronic obstructive pulmonary disease.
林国辉
Chief Physician
Clinical interests
Diagnosis and treatment of chronic obstructive pulmonary disease, bronchial asthma, respiratory failure, massive hemoptysis, pulmonary embolism, tension pneumothorax, acute respiratory distress syndrome, lung tumors and various difficult pulmonary diseases, and multiple organ dysfunction syndrome.
Read more
Diagnosis and treatment of chronic obstructive pulmonary disease, bronchial asthma, respiratory failure, massive hemoptysis, pulmonary embolism, tension pneumothorax, acute respiratory distress syndrome, lung tumors and various difficult pulmonary diseases, and multiple organ dysfunction syndrome.
郑闪闪
Attending Physician
Clinical interests
Precise diagnosis, standardized treatment, and long-term management of common respiratory diseases such as pneumonia, chronic obstructive pulmonary disease, bronchial asthma, and bronchiectasis.